HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.
Zacks
More News
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
Zacks
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.
Zacks
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.
Zacks
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.
Zacks
Is the Options Market Predicting a Spike in Hinge Health Stock?
Investors need to pay close attention to HNGE stock based on the movements in the options market lately.
Zacks
Jim Cramer Recommends Buying This Health Care Stock: 'What A Quarter They Had'
Mad Money Lightning Round analysis: Hinge Health a buy after strong quarter, Stellantis not investible, Tractor Supply time to buy, and Cheniere Energy mixed results.read more...
Benzinga
Cramer's lightning round: Buy Hinge Health
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed...
CNBC: Mad Money with Jim Cramer
Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks
IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
Zacks
Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?
HIMS' second-quarter 2026 results are likely to benefit from weight-loss demand and global expansion even as margin pressures and higher spending linger.